Yield10 Bioscience, Inc. (YTEN) Misses Q4 EPS by $8.05, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. KLAC
9. BIIB
10. ETSY

Go back to Yield10 Bioscience, Inc. (YTEN) Misses Q4 EPS by $8.05, Revenues Miss

Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results

March 19, 2020 4:04 PM EDT

WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2019.

"In 2019 we consistently met our milestones as we brought forward new crop traits in development, generated proof points, and expanded testing of our traits into additional crops," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10 Bioscience. "In 2020 we expect to advance our traits to achieve additional development milestones, continue to build relationships with major agricultural companies, and further demonstrate the commercial... More